Population pharmacokinetics and exposure‐response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID‐19

por Sager, Jennifer E., El‐Zailik, Asma, Passarell, Julie, Roepcke, Stefan, Li, Xiaobin, Aldinger, Melissa, Nader, Ahmed, Skingsley, Andrew, Alexander, Elizabeth L., Yeh, Wendy W., Mogalian, Erik, Garner, Chad, Peppercorn, Amanda, Shapiro, Adrienne E., Reyes, Maribel
Publicado 2023

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

por Moya, Jaynier, Temech, Marisol, Parra, Sergio, Juarez, Erick, Hernandez-Loy, Reinaldo, Gutierrez, Juan C Moises, Diaz, Jorge, Hussain, Rubaba, Segal, Scott, Xu, Claire, Skingsley, Andrew, Schnell, Gretja, El-Zailik, Asma, Sager, Jennifer E, Aldinger, Melissa, Alexander, Elizabeth L, Acloque, Gerard
Publicado 2023